Gene expression in osteoblast cells treated with submicron to nanometer hydroxyapatite-mullite eluate particles

Journal of Biomaterials Applications

Volumn 27, Issue 7, 2013, Pages 891-908

  Kalmodia, Sushma ^a   Basu, Bikramjit ^b   Webster, Thomas J ^c  

^a INDIAN INSTITUTE OF TECHNOLOGY KANPUR   (India)

^b INDIAN INSTITUTE OF SCIENCE   (India)

^c Brown University   (United States)

Author keywords

Bax; Bcl; cbfa; collagen type I; gene expression; Hydroxyapatite; in vitro; mullite; osteoblasts; osteocalcin; particles

Indexed keywords

BAX; BCL; CBFA; COLLAGEN TYPE I; IN-VITRO; OSTEOCALCIN;

COLLAGEN; ELEMENTARY PARTICLES; GENE EXPRESSION; HYDROXYAPATITE; MULLITE; OSTEOBLASTS; SILICATE MINERALS; SPARK PLASMA SINTERING;

CELL DEATH;

ALUMINOSILICIC ACID; ALUMINUM SILICATE; BIOMATERIAL; HYDROXYAPATITE;

APOPTOSIS; ARTICLE; CELL DIFFERENTIATION; CELL LINE; CELL SURVIVAL; CHEMISTRY; CYTOLOGY; DRUG EFFECT; GENE EXPRESSION REGULATION; HUMAN; METABOLISM; OSTEOBLAST; PARTICLE SIZE;

ALUMINUM SILICATES; APOPTOSIS; BIOCOMPATIBLE MATERIALS; CELL DIFFERENTIATION; CELL LINE; CELL SURVIVAL; DURAPATITE; GENE EXPRESSION REGULATION; HUMANS; OSTEOBLASTS; PARTICLE SIZE;

MLCS; MLOWN;

EID: 84873630833     PISSN: 08853282     EISSN: 15308022     Source Type: Journal    
DOI: 10.1177/0885328211430422     Document Type: Article

References (49)

1. Yang L, Sheldon BW, Webster TJ. The impact of diamond nanocrystallinity on osteoblast functions. Biomaterials. 2009 ; 30: 3458-3465
2. Zhang L, Webster TJ. Nanotechnology and nanomaterials: promises for improved tissue regeneration. Nano Today. 2009 ; 4: 66-80
3. Khang D, Lu J, Yao C, Haberstroh KM, Webster TJ. The role of nanometer and sub-micron surface features on vascular and bone cell adhesion on titanium. Biomaterials. 2008 ; 29: 970-983
4. Consolidation-microstructure-property relationships in bulk nanoceramics and ceramic nanocomposites. A review; Int Mater Rev. 2007 ; 52: 257-288
5. Webster TJ, Schadler LS, Siegel RW, Bizios R. Mechanisms of enhanced osteoblast adhesion on nanophase alumina involve vitronectin. Tissue Eng. 2001 ; 7: 291-301
6. In vitro biocompatibility of novel biphasic calcium phosphate-mullite composites. J Biomater Appl. 2011 ;:
7. Kalmodia S, Sharma V, Dhawan A, Basu B. Size and composition dependent cytotoxicity and genotoxicity of hydroxyapatite-mullite. J Nanosci Nanotechnol. :
8. Saha N, Keskinbora K, Suvaci E, Basu B. Sintering, microstructure, mechanical, and antimicrobial properties of HAp-ZnO biocomposites. J Biomed Mater Res Appl Biomater. 2010 ; 95B: 430-440
9. Dubey AK, Tripathi G, Basu B. Characterization of hydroxyapatite- perovskite (CaTiO3) composites: Phase evaluation and cellular response. J Biomed Mater Res Appl Biomater. 2010 ; 95B: 320-329
10. Nath S, Kalmodia S, Basu B. Densification, phase stability and in vitro biocompatibility property of hydroxyapatite-10 wt% silver composites. J Mater Sci Mater Med. 2010 ; 21: 1273-1287
11. Nath S, Basu B, Mohanty M, Mohanan PV. In vivo response of novel calcium phosphate-mullite composites: results up to 12 weeks of implantation. J Biomed Mater Res Appl Biomater. 2009 ; 90B: 547-557
12. Wiren KM, Toombs AR, Semirale AA, Zhang X. Osteoblast and osteocyte apoptosis associated with androgen action in bone: requirement of increased Bax/Bcl-2 ratio. Bone. 2006 ; 38: 637-651
13. Bruce Alberts JL, Johnson A, Lewis J, Raff M, Roberts K and Walter P. Molecular biology of the cell. 4th edn. Garland Science, 2002, pp. 852-870.
14. Setzer B, Bächle M, Metzger MC, Kohal RJ. The gene-expression and phenotypic response of hFOB 1.19 osteoblasts to surface-modified titanium and zirconia. Biomaterials. 2009 ; 30: 979-990
15. Ye Y, Liu J, Xu J, Sun L, Chen M, Lan M. Nano-SiO2 induces apoptosis via activation of p53 and Bax mediated by oxidative stress in human hepatic cell line. Toxicol In Vitro. 2010 ; 24: 751-758
16. Nath S, Kalmodia S, Basu B. Densification, phase stability and in vitro biocompatibility property of hydroxyapatite-10 wt% silver composites. J Mater Sci Mater Med. 2010 ; 21: 1273-1287
17. Nath S, Biswas K, Wang K, Bordia RK, Basu B. Sintering, phase stability, and properties of calcium phosphate-mullite composites. J Am Cer Soc. 2010 ; 93: 1639-1649
18. Nath S, Basu B, Wang K, Bordia RK. Sintering, phase stability and properties of calcium phosphate-mullite composites. J Am Cer Soc. 2010 ; 93: 1639-1649
19. Rathje W. Zur Kenntnis der Phosphate I: Über Hydroxylapatit. Bodenkunde und Pflanzenernährung. 1939 ; 12: 121-128
20. Basu B. and Balani K. Advanced structural ceramics, John Wily and Sons, Inc., October, 2011.
21. Nath S, Biswas K, Basu B. Phase stability and microstructure development in hydroxyapatite-mullite system. Scripta Mater. 2008 ; 58: 1054-1057
22. Ciapetti G, Cenni E, Pratelli L, Pizzoferrato A. In vitro evaluation of cell/biomaterial interaction by MTT assay. Biomaterials. 1993 ; 14: 359-364
23. Thum T, Bauersachs J. Microarray-based gene expression profiling to elucidate cellular responses to nitric oxide-A review from an analytical and biomedical point of view. J Chromatography B. 2007 ; 851: 3-11
24. Zubor P, Hatok J, Galo S, Dokus K, Klobusiakova D, Danko J, et al. Anti-apoptotic and pro-apoptotic gene expression evaluated from eutopic endometrium in the proliferative phase of the menstrual cycle among women with endometriosis and healthy controls. Eur J Obstet Gynecol Reprod Biol. 2009 ; 145: 172-176
25. Frank O, Heim M, Jakob M, Barbero A, Schäfer D, Bendik I, et al. Real-time quantitative RT-PCR analysis of human bone marrow stromal cells during osteogenic differentiation in vitro. J Cell Biochem. 2002 ; 85: 737-746
26. Kalmodia S, Sharma V, Pandey A, Dhawan A, Basu B. Cytotoxicity and genotoxicity property of hydroxyapatite-mullite eluates. J Biomed Nanotechnol. 2011 ; 7: 74-75
27. Vermes I, Haanen C, Reutelingsperger C. Flow cytometry of apoptotic cell death. J Immunol Meth. 2000 ; 243: 167-190
28. de la Fuente M, Ossa CG. Binding to phosphatidyl serine membranes causes a conformational change in the concave face of annexin I. Biophys J. 1997 ; 72: 383-387
29. Shounan Y, Feng X, O'Connell PJ. Apoptosis detection by annexin V binding: a novel method for the quantitation of cell-mediated cytotoxicity. J Immunol Meth. 1998 ; 217: 61-70
30. Bosetti M, Lloyd AW, Santin M, Denyer SP, Cannas M. Effects of phosphatidylserine coatings on titanium on inflammatory cells and cell-induced mineralisation in vitro. Biomaterials. 2005 ; 26: 7572-7578
31. Sano J, Oguma K, Kano R, Yazawa M, Tsujimoto H, Hasegawa A. High expression of Bcl-xL in delayed apoptosis of canine neutrophils induced by lipopolysaccharide. Res Veter Sci. 2005 ; 78: 183-187
32. Lonergan P, Rizos D, Gutiérrez-Adán A, Moreira PM, Pintado B, de la Fuente J, et al. Temporal divergence in the pattern of messenger RNA expression in bovine embryos cultured from the zygote to blastocyst stage in vitro or in vivo. Biol Reprod. 2003 ; 69: 1424-1431
33. Adams JM, Cory S. The Bcl-2 protein family: arbiters of cell survival. Science. 1998 ; 281: 1322-1326
34. Ghassan MS, Zhongliang J, Nicole MF, Michael PD. Modulation of the BCL-2/BAX ratio by interferon-γ and hypoxia in human peritoneal and adhesion fibroblasts. Fertil Steril. 2008 ; 90: 1925-1930
35. Petros AM, Medek A, Nettesheim DG, Kim DH, Yoon HS, Swift K, et al. Solution structure of the antiapoptotic protein bcl-2. Proc Natl Acad Sci USA. 2001 ; 98: 3012-3017
36. Brady HJM, Gil-Gómez G. Molecules in focus Bax. The pro-apoptotic Bcl-2 family member, Bax. Int J Biochem Cell Biol. 1998 ; 30: 647-650
37. Priya A, Nath S, Basu B, Biswas K. In vitro dissolution of calcium phosphate-mullite composite in simulated body fluid. J Mater Sci Mater Med. 2010 ; 21: 1817-1828
38. Thompson C. Apoptosis in the pathogenesis and treatment of disease. Science. 1995 ; 267: 1456-1462
39. Cerone MA, Marchetti A, Bossi G, Blandino G, Sacchi A, Soddu S. p53 is involved in the differentiation but not in the differentiation-associated apoptosis of myoblasts. Cell Death Differen. 2000 ; 7: 506-508
40. Herzenberg AL, Parks D, Sahaf B, Perez O, Roederer M, and Herzenberg L. The History and Future of the Fluorescence Activated Cell Sorter and Flow Cytometry: A View from Stanford. Clinical Chemistry 2002; 48; 1819-1827.
41. Chang BS, Kelekar A, Harris MH, Harlan JE, Fesik SW, Thompson CB. The BH3 domain of Bcl-xS is required for inhibition of the antiapoptotic function of Bcl-xL. Mol Cell Biol. 1999 ; 19: 6673-6681
42. Solovyan V, Bezvenyuk Z, Huotari V, Tapiola T, Salminen A. Distinct mechanisms underlay DNA disintegration during apoptosis induced by genotoxic and nongenotoxic agents in neuroblastoma cells. Neurochem Int. 1999 ; 34: 465-4672
43. Kivinen K, Kallajoki M, Taimen P. Caspase-3 is required in the apoptotic disintegration of the nuclear matrix. Exp Cell Res. 2005 ; 311: 62-73
44. Kato YP, Silver FH. Formation of continuous collagen fibres: evaluation of biocompatibilily and mechanical properties. Biomaterials. 1990 ; 11: 169-175
45. Helary C, Foucault-Bertaud A, Godeau G, Coulomb B, Giraud Guille MM. Fibroblast populated dense collagen matrices: cell migration, cell density and metalloproteinases expression. Biomaterials. 2005 ; 26: 1533-1543
46. Ogata K, Imazato S, Ehara A, Ebisu S, Kinomoto Y, Nakano T, et al. Comparison of osteoblast responses to hydroxyapatite and hydroxyapatite/soluble calcium phosphate composites. J Biomed Mater Res. 2005 ; 72A: 127-135
47. Shu R, McMullen R, Baumann MJ, McCabe LR. Hydroxyapatite accelerates differentiation and suppresses growth of MC3T3-E1 osteoblasts. J Biomed Mater Res. 2003 ; 67A: 1196-1204
48. Blenckè BA, Brömer H, Deutscher KK. Compatibility and long-term stability of glass-ceramic implants. J Biomed Mater Res. 1978 ; 12: 307-316
49. Burg K, Shalaby S, Atkins G Polymer biocompatibility and toxicity. Boca Raton: CRC Press ; 2003 :